This may include use of a vaccine that can be used in wildlife and domestic livestock.doi:10.1128/9781555818050.ch14Whipple, DianaAmerican Society of MicrobiologyWHIPPLE, D., AND M. PALMER. 2000. Reemergence of tuberculosis in animals in the United States. Pages 281-299 in C. Brown and C....
tuberculosis- infection transmitted by inhalation or ingestion of tubercle bacilli and manifested in fever and small lesions (usually in the lungs but in various other parts of the body in acute stages) T.B.,TB infectious disease- a disease transmitted only by a specific kind of contact ...
关键词: Humans Tuberculosis, Multidrug-Resistant Pyrazinamide Ciprofloxacin BCG Vaccine Antitubercular Agents Health Personnel United States DOI: 10.1016/S0962-8479(96)90090-8 被引量: 23 年份: 1996 收藏 引用 批量引用 报错 分享 全部来源 全文购买 Elsevier NCBI Europe PMC ResearchGate www.socolar.com...
Previously, the prevalence of bTB in 1 year old deer provided a useful, if approximate, metric of the rate of new bTB infections in deer, using the rationale that any lesioned animals found in that age group had to have been infected within the past year [4,5]. However, recent trends ...
which have recently been emphasized by Bloom70, concerning the protection triggered by natural MtbC infection against developing active TB (about 97%), and the need to obtain a prophylactic vaccine that can increase this protection while avoiding the risk of fast progression (f) and endogenous reac...
MARTIN C. ET AL.: 'The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs' VACCINE vol. 24, no. 17, April 2006, pages 3408 - 3419, XP005353688 INFANTE E. ET AL.: 'Immunogenicity and ...
Tuberculosis is highly contagious disease that can be transmitted between humans and animals. Asian elephants (Elephas maximus) in captivity live in close contact with humans in many Asian countries. In this study, we developed an interferon gamma releas
Tuberculosis (TB) drug research and development efforts have resurged in the past 10 years to meet urgent medical needs, but enormous challenges remain. Th
A range of vaccine candidates are currently under exploration, including inactivated, live-attenuated, recombinant BCG, protein-adjuvant, viral vectors, DNA, mRNA and virus-like particle-based vaccines [7]. Some of these candidates are in preclinical stages or early clinical trials, while others ...
There is urgent need for new drug regimens that more rapidly cure tuberculosis (TB). Existing TB drugs and regimens vary in treatment-shortening activity, but the molecular basis of these differences is unclear, and no existing assay directly quantifies